Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (81-90 of 349) with videos related to

Pageof 35
Sort By:
Urology|May 12, 2004
Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c diseaseStephen J Freedland, Leslie A Mangold, Jonathan I Epstein, et al.
Cancer|September 17, 2004
Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysisPatrick J Bastian, Leslie A Mangold, Jonathan I Epstein, et al.
BJU International|March 8, 2013
Prognostic Gleason grade grouping: data based on the modified Gleason scoring systemPhillip M Pierorazio, Patrick C Walsh, Alan W Partin, et al.
Cancer|April 10, 2004
Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2bStephen J Freedland, Alan W Partin, Jonathan I Epstein, et al.
Reviews in Urology|September 21, 2006
Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI)Matthew B Gretzer, Alan W Partin, Daniel W Chan, et al.
BJU International|January 29, 2013
Multiple cores of Gleason score 6 correlate with favourable findings at radical prostatectomyCarla L Ellis, Patrick C Walsh, Alan W Partin, et al.
Urology|May 29, 2002
Free prostate-specific antigen in serum is becoming more complexStephen D Mikolajczyk, Leonard S Marks, Alan W Partin, et al.
The Journal of Urology|September 8, 2005
The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomyStephen J Freedland, Leslie A Mangold, Patrick C Walsh, et al.
The Journal of Urology|August 13, 2015
Importance of Reporting the Gleason Score at the Positive Surgical Margin Site: Analysis of 4,082 Consecutive Radical Prostatectomy CasesMax Kates, Nikolai A Sopko, Misop Han, et al.
Urology|March 29, 2008
Does laterality of positive needle biopsy in clinical T2a patients with prostate cancer affect biochemical recurrence-free survival?Ina Wu, Matthew E Nielsen, Misop Han, et al.
Pageof 35

Showing results (81-90 of 349) with videos related to

Sort By:
Pageof 35
Urology|May 12, 2004
Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c diseaseStephen J Freedland, Leslie A Mangold, Jonathan I Epstein, et al.
Cancer|September 17, 2004
Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysisPatrick J Bastian, Leslie A Mangold, Jonathan I Epstein, et al.
BJU International|March 8, 2013
Prognostic Gleason grade grouping: data based on the modified Gleason scoring systemPhillip M Pierorazio, Patrick C Walsh, Alan W Partin, et al.
Cancer|April 10, 2004
Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2bStephen J Freedland, Alan W Partin, Jonathan I Epstein, et al.
Reviews in Urology|September 21, 2006
Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI)Matthew B Gretzer, Alan W Partin, Daniel W Chan, et al.
BJU International|January 29, 2013
Multiple cores of Gleason score 6 correlate with favourable findings at radical prostatectomyCarla L Ellis, Patrick C Walsh, Alan W Partin, et al.
Urology|May 29, 2002
Free prostate-specific antigen in serum is becoming more complexStephen D Mikolajczyk, Leonard S Marks, Alan W Partin, et al.
The Journal of Urology|September 8, 2005
The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomyStephen J Freedland, Leslie A Mangold, Patrick C Walsh, et al.
The Journal of Urology|August 13, 2015
Importance of Reporting the Gleason Score at the Positive Surgical Margin Site: Analysis of 4,082 Consecutive Radical Prostatectomy CasesMax Kates, Nikolai A Sopko, Misop Han, et al.
Urology|March 29, 2008
Does laterality of positive needle biopsy in clinical T2a patients with prostate cancer affect biochemical recurrence-free survival?Ina Wu, Matthew E Nielsen, Misop Han, et al.
Pageof 35